Cargando…
Efficiency of Recombinant Bacille Calmette-Guérin in Inducing Humoral and Cell Mediated Immunities against Human Immunodeficiency Virus Type 1 Third Variable Domain in Immunized Mice
PURPOSE: The third variable (V3) loop of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein has been intensively studied for AIDS vaccine development. Bacille Calmette-Guérin (BCG) is widely used to immunize against tuberculosis and has many advantages as a vaccine vehicle, such a...
Autor principal: | Kim, Young Jae |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017694/ https://www.ncbi.nlm.nih.gov/pubmed/21155051 http://dx.doi.org/10.3349/ymj.2011.52.1.173 |
Ejemplares similares
-
Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
por: Ehtesham, Nasreen Zafar, et al.
Publicado: (2020) -
Bacille Calmette-Guérin: An ophthalmic perspective
por: Jain, Manish, et al.
Publicado: (2022) -
Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin’s Specific and Nonspecific Effects?
por: Schaltz-Buchholzer, Frederik
Publicado: (2022) -
Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011) -
Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)